The insulin-like growth factor-I receptor gene: a downstream target for oncogene and tumor suppressor action

Haim Werner, Sharon Maor

Research output: Contribution to journalReview articlepeer-review

Abstract

The insulin-like growth factor-I receptor (IGF-IR) mediates the biological actions of both IGF-I and IGF-II. The IGF-IR is expressed in most transformed cells, where it displays potent antiapoptotic and cell-survival activities. IGF-IR levels are tightly regulated by the concerted action of secreted (e.g. peptide and steroid hormones, growth factors and cytokines) and cellular (e.g. transcription factors, oncogenes and tumor suppressors) factors. The mode of action of many tumor suppressors involves transcriptional suppression of the IGF-IR gene, with a subsequent reduction in cell-surface IGF-IR concentrations and IGF-I action. Loss-of-function mutation of tumor suppressors, a common theme in human cancer, can lead to aberrant regulation of IGF-IR gene expression.

Original languageEnglish
Pages (from-to)236-242
Number of pages7
JournalTrends in Endocrinology and Metabolism
Volume17
Issue number6
DOIs
StatePublished - Aug 2006

Fingerprint

Dive into the research topics of 'The insulin-like growth factor-I receptor gene: a downstream target for oncogene and tumor suppressor action'. Together they form a unique fingerprint.

Cite this